The ZEISS CLARUS 700 is the first fundus camera to combine an ultra-widefield of view with True colour high-resolution imaging. And now it comes with a full suite of imaging capabilities – including fluorescein angiography – and advanced features to collect the best image, every time.
A Turkish study has shown that some patients had significant alterations in corneal and lenticular densitometric values following Covid-19 infection.
Glaucoma New Zealand (GNZ) is launching a new online education programme for optometrists, developed by University of Auckland Professor Helen Danesh-Meyer, a founding trustee of GNZ, and Dr Hannah Kersten.
Despite being planned as a hybrid event, the annual Cornea and Contact Lens Society (CCLS) conference planned for 10-12 March 2022 has been postponed due to modelling of the Covid-19 Omicron variant suggesting a peak in March.
Researchers at the University of Virginia School of Medicine (UVA), US, have found that lupus and atrophic macular degeneration share an inflammatory pathway.
Early detection of glaucoma saved the sight and the remarkable career of late US senator and pioneering astronaut John Glenn (1921-2016).
A study by Guangdong Academy of Medical Sciences, China, and including researchers in Melbourne, has associated mortality risk with retinal age gap. Researchers led by Professor Mingguang He, Centre
A study conducted by the Centre for Ocular Research & Education (CORE) indicates that a novel combination of omega-3 and -6 fatty acids as a dietary supplement significantly improves symptoms in
Researchers in the UK have trained an artificial intelligence (AI) system to identify patients likely to have a heart attack from their retinal scans. Writing in Nature Machine Intelligence, an
Glaukos has announced its iDose TR travoprost implant has demonstrated intraocular pressure (IOP) reduction and favourable safety profile over 36 months in a phase 2b study. Of the study’s 154
A three-year study of Alimera Sciences’ Iluvien corticosteroid intravitreal implant (FAc) has demonstrated improved visual outcomes and reduced treatment burden in diabetic macular oedema (DMO)
Reper’s prosthetic iris for traumatic aphakia and aniridia patients is now available in New Zealand via Medix21. The country’s first implantation was completed in Christchurch in December 2021.